Anti-acetaminophen antibodies and acetaminophen protein adducts

The present disclosure provides isolated antibodies that bind to acetaminophen-protein adducts that are useful in the detection and diagnosis of acetaminophen-induced toxicity.

ABSTRACT

The present disclosure provides isolated antibodies that bind to acetaminophen-protein adducts that are useful in the detection and diagnosis of acetaminophen-induced toxicity.

CLAIMS

1. An immunoassay comprising at least one isolated antibody which specifically binds an acetaminophen-protein adduct but does not specifically bind free acetaminophen, wherein the antibody comprises: (a) a light chain CDR1 amino acid sequence of SEQ ID NO:21; (b) a light chain CDR2 amino acid sequence of SEQ ID NO:22; (c) a light chain CDR3 amino acid sequence of LGh; wherein h is a hydrophobic amino acid; (d) a heavy chain CDR1 amino acid sequence of YXI, wherein X is any amino acid; (e) a heavy chain CDR2 amino acid sequence of SEQ ID NO:23; and (f) a heavy chain CDR3 amino acid sequence of SEQ ID NO:24.

PATENT INFORMATION


Interested in this Technology?

The technologies listed here are available for licensing or for developmental partnership.
Please contact us if you have any questions, or if you would like further information on these or other upcoming BioVentures technologies.

Contact